Literature DB >> 23911970

Hormones and arterial stiffness in patients with chronic kidney disease.

Ozkan Gungor1, Fatih Kircelli, Luminita Voroneanu, Adrian Covic, Ercan Ok.   

Abstract

Cardiovascular disease constitutes the major cause of mortality in patients with chronic kidney disease. Arterial stiffness is an important contributor to the occurrence and progression of cardiovascular disease. Various risk factors, including altered hormone levels, have been suggested to be associated with arterial stiffness. Based on the background that chronic kidney disease predisposes individuals to a wide range of hormonal changes, we herein review the available data on the association between arterial stiffness and hormones in patients with chronic kidney disease and summarize the data for the general population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23911970     DOI: 10.5551/jat.18580

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  4 in total

1.  Prolactin as a predictor of endothelial dysfunction and arterial stiffness progression in menopause.

Authors:  G Georgiopoulos; I Lambrinoudaki; F Athanasouli; E Armeni; A Koliviras; A Augoulea; D Rizos; C Papamichael; A Protogerou; K Stellos; K Stamatelopoulos
Journal:  J Hum Hypertens       Date:  2017-03-23       Impact factor: 3.012

Review 2.  Neuroimmunoendocrine Link Between Chronic Kidney Disease and Olfactory Deficits.

Authors:  Rebeca Corona; Benito Ordaz; Ludivina Robles-Osorio; Ernesto Sabath; Teresa Morales
Journal:  Front Integr Neurosci       Date:  2022-01-31

3.  Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study.

Authors:  Niki Katsiki; Erietta Kollari; Sotirios Dardas; Petros Dardas; Anna-Bettina Haidich; Vasilios G Athyros; Asterios Karagiannis
Journal:  Open Cardiovasc Med J       Date:  2016-05-23

4.  Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality.

Authors:  Agne Laucyte-Cibulskiene; Liam J Ward; Valeria Raparelli; Karolina Kublickiene; Thomas Ebert; Giulia Tosti; Claudia Tucci; Leah Hernandez; Alexandra Kautzky-Willer; Maria-Trinidad Herrero; Colleen M Norris; Louise Pilote; Magnus Söderberg; Torkel B Brismar; Jonaz Ripsweden; Peter Stenvinkel
Journal:  Biol Sex Differ       Date:  2021-09-15       Impact factor: 5.027

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.